CPQME-10-2-261.pdf

The novel Corona Virus disease (COVID-19) has changed a lot of procedures, not just in the

norms of society but also how we manage patients. Current data shows that COVID-19 is largely

contracted by person to person transmission and people with co-morbidities such as cancer are at a

higher risk of contracting the virus. Breast cancer is amongst the most common cancers in women

worldwide and certain medications used for its treatment as well as the surgical interventions and

hospital/out-patient visits put them more at a risk. This literature review seeks to address the current

approaches in the management of breast cancer patients and to ascertain which methods will best

limit their exposure as well as reduce their risk of contracting COVID-19.